Cancer touches nearly every family in Delaware. But based on new data released by the Delaware Division of Public Health, there's reason for hope.
Between 2008 and 2022, cancer mortality rates decreased by an average of 1.5% per year in both Delaware and the United States. The most important reasons are surprisingly practical: better cancer screening, better follow-up, and better support for patients once the process starts.
To better explain the progress that's been made and where more work needs to be done, we're joined by Dr. Thomas Schwaab, the Bank of America Endowed Medical Director of ChristianaCare's Helen F. Graham Cancer Center and Research Institute, and cancer survivor and patient advocate Bill Osborne. We get specific about how modern screening works in real life, including details on low-dose CT scans for lung cancer, mammography for breast cancer, PSA tests for prostate cancer, and more. We look at barriers to screening and treatment, and how medical professionals are working to minimize those issues. And we explore the important work of clinical trials as a means to advance treatment options and "pay forward" better care.
The work is far from over, but the ChristianaCare cancer community is ready to help. If you want clear next steps and a hopeful, grounded look at prevention, listen now, and find out how your own cancer journey may ease the stress for future patients.
Thomas Schwaab, M.D., Ph.D. is the Bank of America Endowed Medical Director of ChristianaCare's Helen F. Graham Cancer Center and Research Institute and leader of the Cancer Service Line, as well as an innovative and energetic board-certified urological surgeon. Dr. Schwaab provides overall direction and leadership for the Graham Cancer Center and cancer care activities. He directs community outreach and research and works to reduce the incidence, prevalence and mortality of cancer in the state of Delaware and the region.
Links:
- ChristianaCare Helen F. Graham Cancer Center & Research Institute
- ChristianaCare Oncology Patient Advocates for Clinical Trials (OPACT)
- ChristianaCare Cancer Clinical Trials
- ChristianaCare News: Graham Cancer Center's Commitment to Clinical Trials Opens Doors for Patients
- Delaware Division of Public Health Releases Latest Cancer Incidence and Mortality Trends in Delaware
Cancer touches nearly every family in Delaware. But based on new data released by the Delaware Division of Public Health, there's reason for hope.
Between 2008 and 2022, cancer mortality rates decreased by an average of 1.5% per year in both Delaware and the United States. The most important reasons are surprisingly practical: better cancer screening, better follow-up, and better support for patients once the process starts.
To better explain the progress that's been made and where more work needs to be done, we're joined by Dr. Thomas Schwaab, the Bank of America Endowed Medical Director of ChristianaCare's Helen F. Graham Cancer Center and Research Institute, and cancer survivor and patient advocate Bill Osborne. We get specific about how modern screening works in real life, including details on low-dose CT scans for lung cancer, mammography for breast cancer, PSA tests for prostate cancer, and more. We look at barriers to screening and treatment, and how medical professionals are working to minimize those issues. And we explore the important work of clinical trials as a means to advance treatment options and "pay forward" better care.
The work is far from over, but the ChristianaCare cancer community is ready to help. If you want clear next steps and a hopeful, grounded look at prevention, listen now, and find out how your own cancer journey may ease the stress for future patients.
Thomas Schwaab, M.D., Ph.D. is the Bank of America Endowed Medical Director of ChristianaCare's Helen F. Graham Cancer Center and Research Institute and leader of the Cancer Service Line, as well as an innovative and energetic board-certified urological surgeon. Dr. Schwaab provides overall direction and leadership for the Graham Cancer Center and cancer care activities. He directs community outreach and research and works to reduce the incidence, prevalence and mortality of cancer in the state of Delaware and the region.
Links:
- ChristianaCare Helen F. Graham Cancer Center & Research Institute
- ChristianaCare Oncology Patient Advocates for Clinical Trials (OPACT)
- ChristianaCare Cancer Clinical Trials
- ChristianaCare News: Graham Cancer Center's Commitment to Clinical Trials Opens Doors for Patients
- Delaware Division of Public Health Releases Latest Cancer Incidence and Mortality Trends in Delaware
